Pricing

Chimeric Therapeutics

0 followers

‌

Chimeric Therapeutics is the ASX leader in cell therapy.

As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most potential for patients.

ASX: CHM

Industries

Biotechnology, Health Care

Employees

1-10

Links

Org chart

Dr Rebecca McQualter

Chief Executive Officer

Collapse

Jason Litten

Chief Medical Officer

Stephanie Astrow

Chief Scientific Officer

Alison Gartner

Project Manager

Eric Sullivan

Board Of Directors, Chair Of Audit & Risk Committee, Member Of Remuneration & Nomination Committee

Paul Hopper

Executive Chairman & Founder

Teams

This company has no teams yet

Offices

This company has no offices yet

Similar companies

Revvity

8 followers

QNTM Labs

4 followers

Merck

277 followers

Cellworks

2 followers

Pfizer

606 followers

Vantive

3 followers

Amgen

275 followers

Pharmanovia

2 followers

Just - Evotec Biologics

1 follower

BioLife Plasma Services

1 follower

Biocon Biologics

8 followers

Explore companies